Financials

  • Market Capitalization 375.39 M
  • Employee 45
  • Founded 2019
  • CEO N/A
  • Website www.x4pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1CYH8
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-2
市销率
11.96

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
3145
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.74 USD+0.85%0.00%+7.73%+47.66%379.33 M USD
3147
ENTA
Enanta Pharmaceuticals, Inc. - Common Stock
13.10 USD-0.08%-8.07%+14.51%+98.79%380.93 M USD
3179
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.63 USD+0.22%-7.40%-1.91%+11.30%363.56 M USD
3207
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.83 USD-0.34%-9.05%-0.85%+5.42%350.59 M USD

新闻